Background: The allergy preventive effects of gut immune modulation by bacterial compounds are still not fully understood.
Objective: We sought to evaluate the effect of bacterial lysate applied orally from the second until seventh months of life on the prevalence of allergic diseases at school age.
Methods: In a randomized, placebo-controlled trial, 606 newborns with at least one allergic parent received orally a bacterial lysate consisting of heat-killed Gram-negative Escherichia coli Symbio and Gram-positive Enterococcus faecalis Symbio or placebo from week 5 until the end of month 7. A total of 402 children were followed until school age (6-11 years) for the assessment of current atopic dermatitis (AD), allergic rhinitis (AR), asthma and sensitization against aeroallergens.
Results: AD was diagnosed in 11.0% (22/200) of children in the active and in 10.4% (21/202) of children in the placebo group. AR was diagnosed in 35% (70/200) of children in the active and in 38.1% (77/202) children in the placebo group. Asthma was diagnosed in 9% (18/199) of children in the active and in 6.6% (13/197) of children in the placebo group. Sensitization occurred in 46.5% (66/142) of participants in the active and 51.7% (76/147) in the placebo group.
Conclusion: An oral bacterial lysate of heat-killed Gram-negative Escherichia coli and Gram-positive Enterococcus faecalis applied during the first 7 months of life did not influence the development of AD, asthma and AR at school age.
Keywords: asthma; atopic dermatitis; prevention; rhinitis.
© 2020 The Authors. Allergy published by John Wiley & Sons Ltd.
Oral application of bacterial lysate in infancy decreases the risk of atopic dermatitis in children with 1 atopic parent in a randomized, placebo-controlled trial.J Allergy Clin Immunol. 2012 Apr;129(4):1040-7. doi: 10.1016/j.jaci.2012.02.005. J Allergy Clin Immunol. 2012. PMID: 22464674 Clinical Trial.
Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.Pediatr Allergy Immunol. 2004 Jun;15 Suppl 16:4-5, 9-32. doi: 10.1111/j.1399-3038.2004.0148b.x. Pediatr Allergy Immunol. 2004. PMID: 15125698 Review.
Development of Respiratory Allergies, Asthma and Allergic Rhinits in Children with Atopic Dermatitis.Acta Clin Croat. 2017 Jun;56(2):308-317. doi: 10.20471/acc.2017.56.02.15. Acta Clin Croat. 2017. PMID: 29485799
Cost-effectiveness analysis, prevention of atopic dermatitis by oral application of bacterial lysate in newborns/small children.Eur J Health Econ. 2013 Dec;14(6):995-1002. doi: 10.1007/s10198-012-0448-x. Epub 2012 Dec 15. Eur J Health Econ. 2013. PMID: 23242758 Clinical Trial.
Oral application of bacterial lysate in infancy diminishes the prevalence of atopic dermatitis in children at risk for atopy.Benef Microbes. 2014 Jun 1;5(2):147-9. doi: 10.3920/BM2013.0007. Benef Microbes. 2014. PMID: 23886978 Review.
- von Mutius E, Vercelli D. Farm living: effects on childhood asthma and allergy. Nature Rev Immunol. 2010;10(12):861-868.
- Ege MJ, Herzum I, Buchele G, et al. Prenatal exposure to a farm environment modifies atopic sensitization at birth. J Allergy Clin Immunol. 2008;122(2):407-412, 12 e1-4.
- Alfven T, Braun-Fahrlander C, Brunekreef B, et al. Allergic diseases and atopic sensitization in children related to farming and anthroposophic lifestyle-the PARSIFAL study. Allergy. 2006;61(4):414-421.
- Ege MJ. Intestinal microbial diversity in infancy and allergy risk at school age. J Allergy Clin Immunol. 2011;128(3):653-654.
- Ege M, Bieli C, Frei R, et al. Prenatal farm exposure is related to the expression of receptors of the innate immunity and to atopic sensitization in school-age children. J Allergy Clin Immunol. 2006;117(4):817-823.